Nicolas J Schlienz1, Alan J Budney2, Dustin C Lee1, Ryan Vandrey1. 1. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224. 2. Department of Psychiatry, Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth, Lebanon, NH 03766.
Abstract
PURPOSE OF REVIEW: This report provides an updated overview of pre-clinical and clinical research on the etiology and biological substrates of the cannabis withdrawal syndrome. RECENT FINDINGS: Long-term cannabis use is associated with downregulation of type-1 cannabinoid receptors (CB1). Reduced CB1 receptor density is related to increased withdrawal during early abstinence, and the reduction in CB1 receptor density reverses with extended abstinence. Females have been shown to have increased rate and severity of a subset of cannabis withdrawal symptoms compared with men. SUMMARY: Recent studies have extended knowledge of the biological processes and individual difference variables that influence cannabis withdrawal. However, caveats include small sample sizes in clinical studies, participant samples that are predominantly male, and limited examinations of endocannabinoids, enzymes that degrade endocannabinoids, negative allosteric modulators, and other neurobiological systems that may directly impact cannabis withdrawal symptom expression.
PURPOSE OF REVIEW: This report provides an updated overview of pre-clinical and clinical research on the etiology and biological substrates of the cannabis withdrawal syndrome. RECENT FINDINGS: Long-term cannabis use is associated with downregulation of type-1 cannabinoid receptors (CB1). Reduced CB1 receptor density is related to increased withdrawal during early abstinence, and the reduction in CB1 receptor density reverses with extended abstinence. Females have been shown to have increased rate and severity of a subset of cannabis withdrawal symptoms compared with men. SUMMARY: Recent studies have extended knowledge of the biological processes and individual difference variables that influence cannabis withdrawal. However, caveats include small sample sizes in clinical studies, participant samples that are predominantly male, and limited examinations of endocannabinoids, enzymes that degrade endocannabinoids, negative allosteric modulators, and other neurobiological systems that may directly impact cannabis withdrawal symptom expression.
Entities:
Keywords:
Cannabis; Cannabis Use Disorder; Endocannabinoid System; Marijuana; THC; Withdrawal
Authors: Deepak Cyril D'Souza; Jose A Cortes-Briones; Mohini Ranganathan; Halle Thurnauer; Gina Creatura; Toral Surti; Beata Planeta; Alexander Neumeister; Brian Pittman; Marc Normandin; Michael Kapinos; Jim Ropchan; Yiyun Huang; Richard E Carson; Patrick D Skosnik Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2016-01-01
Authors: Dayong Lee; Jennifer R Schroeder; Erin L Karschner; Robert S Goodwin; Jussi Hirvonen; David A Gorelick; Marilyn A Huestis Journal: Am J Addict Date: 2014 May-Jun
Authors: Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall Journal: Nat Rev Dis Primers Date: 2021-02-25 Impact factor: 52.329
Authors: Brian D Kangas; Ani S Zakarian; Kiran Vemuri; Shakiru O Alapafuja; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman Journal: J Pharmacol Exp Ther Date: 2019-10-22 Impact factor: 4.030
Authors: Shikha Prashad; Ryan P Hammonds; Amanda L Wiese; Amber L Milligan; Francesca M Filbey Journal: Drug Alcohol Depend Date: 2020-02-19 Impact factor: 4.492
Authors: Christina M Ruiz; Alexa Torrens; Erik Castillo; Christina R Perrone; Jenny Cevallos; Victoria C Inshishian; Eden V Harder; Drew N Justeson; Marilyn A Huestis; Vivek Swarup; Daniele Piomelli; Stephen V Mahler Journal: Neuropsychopharmacology Date: 2020-09-14 Impact factor: 7.853